🇺🇸 FDA

Company profile · Sponsor

Johnson

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

A93E2F5 · NMPA pharma CN
Pipeline
7
Drugs
0
Patents
0

Quick answer

Johnson (A93E2F5) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker A93E2F5
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (7)

Search pipeline →

  1. Doripenem

    Johnson

    Ventilator-Associated Pneumonia

    phase 3 small molecule terminated

    1 trial

  2. JNJ-90301900 (NBTXR3)

    Johnson

    Carcinoma, Squamous Cell

    phase 3 small molecule active

    1 trial

  3. Placebo

    Johnson

    Schizoaffective Disorder

    phase 3 small molecule completed

    1 trial

  4. Placebo

    Johnson

    Erectile Dysfunction

    phase 3 small molecule completed

    1 trial

  5. Rivaroxaban

    Johnson

    Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

  6. Rivaroxaban 2.5 mg

    Johnson

    Acute Coronary Syndrome

    phase 3 small molecule completed

    1 trial

  7. Trabectedin

    Johnson

    Ovarian Cancer

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is Johnson?

Johnson (A93E2F5) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Johnson sponsor?

We track 7 ClinicalTrials.gov-linked programs for Johnson, including Doripenem and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Johnson company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.